REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
30/03/2026
Voltar para busca
Dado oficial do USPTO
FAST-TRACK DIAGNOSTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
49
Atualização mais recente
03/04/2026
Tipo de marca
Mista
Classes Nice
1, 5, 10
Data de depósito
22/05/2019
Data de registro
30/03/2021
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/03/2021
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
16
Localização do titular
LU
Examinador
SAITO, KIM
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "FAST-TRACK DIAGNOSTICS" in black with the wording "FAST-TRACK" appearing above the word "DIAGNOSTICS" with two red greater than symbols side by side to the left of the wording.
Titulares e representantes
Titulares
Fast-Track Diagnostics Luxembourg S.a.r.l.
Representantes
Marie Anne Mastrovito Womble Bond Dickinson (US) LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry; chemicals for use in science; chemical preparations for analytical and diagnostic purposes in laboratory use other than for medical or veterinary purposeschemical preparations for analytical and diagnostic purposesreagent kits comprising oligonucleotides and polynucleotidespolymerase and buffer for use in the biotechnology fields; proteins for immunoassay for medical research purposes in the field of detection of cancersbacteriafungiautoimmune diseaseinfectiongastrointestinal disorders and diseasesvirusessexually transmitted diseasesinfluenzaliver diseasesblood diseases and disorderscardiovascular diseaseliver dysfunctionkidney dysfunctioninflammatory disease and for toxicological studies for scientific use; chemical productsproteins for immunoassay for scientific and medical research; chemicalsproteins for analytical purposesdiagnostic purposes and medical research useother than for medical and veterinary use; laboratory testing chemicals and reagents for research purposes containing proteins and immunoassay reagents; chemicalsproteins for analytical purposesdiagnostic purposes for medical research use other than for medical and veterinary use; laboratory chemicalsantibody reagent used for the detection of antigens in cell and tissue and body fluid sample analysis for in vitro diagnostic use; laboratory chemicals for analytical purposes other than for medical and veterinary use; biological reagents for use in molecular biologyother than for medical and veterinary use; chemical test reagents for scientific and research use
Classe 5
Diagnostic preparations for medical or veterinary purposes; pharmaceutical preparations for treatment of cancersbacterial infectionsfungal infectionsviral infectionsautoimmune diseasegastrointestinal disorders and diseasesvirusessexually transmitted diseasesinfluenzaliver diseasesblood diseases and disorderscardiovascular diseaseliver dysfunctionkidney dysfunctioninflammatory diseases; chemicals for medical purposesfor use in the treatment and prevention of treatment of cancersbacterial infectionsfungal infectionsviral infectionsautoimmune diseasegastrointestinal disorders and diseasesvirusessexually transmitted diseasesinfluenzaliver diseasesblood diseases and disorderscardiovascular diseaseliver dysfunctionkidney dysfunctioninflammatory diseases; diagnostic proteins for medical laboratory analysisprotein and nucleic acid arrays for diagnostic purposes used in medical laboratories; diagnostic reagents for medical and veterinary use; reagents for medical and veterinary use; chemical reagents for medical or veterinary purposes; chemical reagents for use in medicine
Classe 10
Testinganalysis and diagnostic apparatus and instruments for medical diagnostic purposesPCR thermocyclerimmunoassay analyzersclinical chemistry analyzersmedical diagnostic instruments for analysis of body fluidsmedical instruments for analyzing and identifying bacteriaflow cytometers for medical diagnostic uses
Publicações
Histórico de despachos e eventos da marca no USPTO.
49 publicações encontradas
RNWL
INTERNATIONAL REGISTRATION RENEWED
25/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/07/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
22/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/07/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/09/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/09/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/07/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
01/07/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
30/03/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
13/02/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/01/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/01/2021
PUBO
PUBLISHED FOR OPPOSITION
12/01/2021
GPNX
NOTIFICATION PROCESSED BY IB
09/01/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/12/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
07/12/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/12/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
07/12/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/11/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/11/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
15/06/2020
GNFR
FINAL REFUSAL E-MAILED
15/06/2020
CNFR
FINAL REFUSAL WRITTEN
15/06/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
19/05/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/05/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
19/05/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/04/2020
RFNT
REFUSAL PROCESSED BY IB
13/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/11/2019
RFRR
REFUSAL PROCESSED BY MPU
14/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/10/2019
CNRT
NON-FINAL ACTION WRITTEN
23/10/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/09/2019
MAFR
APPLICATION FILING RECEIPT MAILED
10/09/2019
DOCK
ASSIGNED TO EXAMINER
04/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/09/2019
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
22/08/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FAST-TRACK DIAGNOSTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.